scispace - formally typeset
U

Uwe Scherf

Researcher at Food and Drug Administration

Publications -  35
Citations -  20122

Uwe Scherf is an academic researcher from Food and Drug Administration. The author has contributed to research in topics: Gene expression profiling & Cancer. The author has an hindex of 22, co-authored 35 publications receiving 19372 citations. Previous affiliations of Uwe Scherf include Johns Hopkins University & National Institutes of Health.

Papers
More filters
Journal ArticleDOI

Exploration, normalization, and summaries of high density oligonucleotide array probe level data

TL;DR: There is no obvious downside to using RMA and attaching a standard error (SE) to this quantity using a linear model which removes probe-specific affinities, and the exploratory data analyses of the probe level data motivate a new summary measure that is a robust multi-array average (RMA) of background-adjusted, normalized, and log-transformed PM values.
Journal ArticleDOI

Systematic variation in gene expression patterns in human cancer cell lines.

TL;DR: Using cDNA microarrays to explore the variation in expression of approximately 8,000 unique genes among the 60 cell lines used in the National Cancer Institute's screen for anti-cancer drugs provided a novel molecular characterization of this important group of human cell lines and their relationships to tumours in vivo.
Journal ArticleDOI

The MicroArray Quality Control (MAQC) project shows inter- and intraplatform reproducibility of gene expression measurements

Leming Shi, +136 more
- 01 Sep 2006 - 
TL;DR: This study describes the experimental design and probe mapping efforts behind the MicroArray Quality Control project and shows intraplatform consistency across test sites as well as a high level of interplatform concordance in terms of genes identified as differentially expressed.
Journal ArticleDOI

A gene expression database for the molecular pharmacology of cancer

TL;DR: Gene-drug relationships for the clinical agents 5-fluorouracil and L-asparaginase exemplify how variations in the transcript levels of particular genes relate to mechanisms of drug sensitivity and resistance.
Journal ArticleDOI

The Microarray Quality Control (MAQC)-II study of common practices for the development and validation of microarray-based predictive models

Leming Shi, +201 more
- 01 Aug 2010 - 
TL;DR: P predictive models for classifying a sample with respect to one of 13 endpoints indicative of lung or liver toxicity in rodents, or of breast cancer, multiple myeloma or neuroblastoma in humans are generated.